Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

MPA increases cancer spread by boosting Eph A2 activity.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Plasmalogens activate a channel in cells that may stimulate hair growth.

Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.

Ginsenoside Rg4 from ginseng may help hair growth by activating certain cell signals.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

TQC shows promise for better hair regrowth in treating hair loss.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

The document's content could not be processed.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.